newsfilter
← Latest News
Business Wire·

TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx

GoodRx has agreed to acquire vitaCare for $150 million in cash, with an additional $7 million consideration contingent upon vitaCare's financial performance through 2023 TherapeuticsMD, Inc. ("TXMD" or the "Company") (NASDAQ:TXMD), an innovative, lea